The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
Open accessAbstract
Atherosclerosis is an immuno-metabolic disease involving chronic inflammation, oxidative stress, epigenetics, and metabolic dysfunction. There is compelling evidence suggesting numerous modifications including the change of the size, density, and biochemical properties in the low-density lipoprotein (LDL) within the vascular wall. These modifications of LDL, in addition to LDL transcytosis and retention, contribute to the initiation, development and clinical consequences of atherosclerosis. Among different atherogenic modifications of LDL, oxidation represents a primary modification. A series of pathophysiological changes caused by oxidized LDL (oxLDL) enhance the formation of foam cells and atherosclerotic plaques. OxLDL also promotes the development of fatty streaks and atherogenesis through induction of endothelial dysfunction, formation of foam cells, monocyte chemotaxis, proliferation and migration of SMCs, and platelet activation, which culminate in plaque instability and ultimately rupture. This article provides a concise review of the formation of oxLDL, enzymes mediating LDL oxidation, and the receptors and pro-atherogenic signaling pathways of oxLDL in vascular cells. The review also explores how oxLDL functions in different stages of endothelial dysfunction and atherosclerosis. Future targeted pathways and therapies aiming at reducing LDL oxidation and/or lowering oxLDL levels and oxLDL-mediated pro-inflammatory responses are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shan, H., Guo, D., Zhang, S., Qi, H., Liu, S., Du, Y., He, Y., Wang, B., Xu, M. G., & Yu, X. (2020) · Cell & Bioscience · doi:10.1186/s13578-019-0371-2 · Cited by 34
RetractedNitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,551
THE ULTRASTRUCTURAL BASIS OF CAPILLARY PERMEABILITY STUDIED WITH PEROXIDASE AS A TRACER
Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.35.1.213 · Cited by 1,491
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Self-citationFrom the American Association of Neurological Surgeons (AANS), A. S. O. N. (., Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., et al. (2018) · International Journal of Stroke · doi:10.1177/1747493018778713 · Cited by 915
Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., Hirsch, J. A., et al. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.11.026 · Cited by 686
Evrard, S. M., Lecce, L., Michelis, K. C., Nomura-Kitabayashi, A., Pandey, G., Purushothaman, K.-R., d’Escamard, V., Li, J. R., Hadri, L., Fujitani, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11853 · Cited by 620
Bai, T., Li, M., Liu, Y., Qiao, Z., & Wang, Z. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.026 · Cited by 532
Vink, H., Constantinescu, A. A., & Spaan, J. A. E. (2000) · Circulation · doi:10.1161/01.cir.101.13.1500 · Cited by 391
Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
Poznyak, A. V., Nikiforov, N. G., Markin, A. M., Kashirskikh, D. A., Myasoedova, V. A., Gerasimova, E. V., & Orekhov, A. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.613780 · Cited by 370
Tombor, L. S., John, D., Glaser, S. F., Luxán, G., Forte, E., Furtado, M., Rosenthal, N., Baumgarten, N., Schulz, M. H., Wittig, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20905-1 · Cited by 301
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293
Self-citationSimionescu, N., Vasile, E., Lupu, F., Popescu, G., & Simionescu, M. (1986) · PubMed Central · Cited by 268
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 226
Self-citationInflamm-Aging: A New Mechanism Affecting Premature Ovarian Insufficiency
Huang, Y., Hu, C., Ye, H., Luo, R., Fu, X., Li, X., Huang, J., Chen, W., & Zheng, Y. (2019) · Journal of Immunology Research · doi:10.1155/2019/8069898 · Cited by 200
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Xu, S., Kamato, D., Little, P. J., Nakagawa, S., Pelisek, J., & Jin, Z. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.003 · Cited by 173
Self-citationBian, W., Jing, X., Yang, Z., Shi, Z., Chen, R., Xu, A., Wang, N., Jiang, J., Yang, C., Zhang, D., et al. (2020) · Aging · doi:10.18632/aging.103034 · Cited by 170
Oxidized low‐density lipoprotein in inflammation‐driven thrombosis
Obermayer, G., Afonyushkin, T., & Binder, C. J. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13925 · Cited by 141
Trained Immunity and Reactivity of Macrophages and Endothelial Cells
Drummer, C., Saaoud, F., Shao, Y., Sun, Y., Xu, K., Lu, Y., Ni, D., Atar, D., Jiang, X., Wang, H., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315452 · Cited by 135
Peng, L., Zhong, X., Li, J., Liu, H., Ma, X., He, R., & Zhao, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.049 · Cited by 132
Antioxidants and coronary artery disease: from pathophysiology to preventive therapy
Leopold, J. A. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000187 · Cited by 131
Jiang, Y.-H., Jiang, L., Wang, Y.-C., Ma, D., & Li, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00512 · Cited by 126
Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway
Feng, Z., Wang, C., Jin, Y., Meng, Q., Wu, J., & Sun, H. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1961823 · Cited by 117
Natural products: The role and mechanism in low‐density lipoprotein oxidation and atherosclerosis
Zhang, S., Li, L., Chen, W., Xu, S., Feng, X., & Zhang, L. (2020) · Phytotherapy Research · doi:10.1002/ptr.7002 · Cited by 107
Self-citationTargeting LOX‐1 in atherosclerosis and vasculopathy: current knowledge and future perspectives
Tian, K., Ogura, S., Little, P. J., Xu, S., & Sawamura, T. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13984 · Cited by 97
Self-citationJin, X., Fu, W., Zhou, J., Shuai, N., Yang, Y., & Wang, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5020 · Cited by 96
LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway
Li, H., Zhao, Q., Chang, L., Wei, C., Bei, H., Yin, Y., Chen, M., Wang, H., Liang, J., & Wu, Y. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1006-7 · Cited by 88
oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic Reprogramming
Groh, L. A., Ferreira, A. V., Helder, L. S., van der Heijden, C. D. C. C., Novakovic, B., van de Westerlo, E., Matzaraki, V., Moorlag, S. J. C. F. M., de Bree, L. C. J., Koeken, V. A. C. M., et al. (2021) · Immunometabolism · doi:10.20900/immunometab20210025 · Cited by 78
Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis.
Jialal, I., & Fuller, C. J. (1995) · PubMed · Cited by 75
PM2 .5 induces endothelial dysfunction via activating NLRP3 inflammasome
Hu, T., Zhu, P., Liu, Y., Zhu, H., Geng, J., Wang, B., Yuan, G., Peng, Y., & Xu, B. (2021) · Environmental Toxicology · doi:10.1002/tox.23309 · Cited by 72
Impact of LDL carotenoid and α-tocopherol content on LDL oxidation by endothelial cells in culture
Dugas, T. R., Morel, D. W., & Harrison, E. H. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33867-0 · Cited by 66
Chen, M., Li, W., Zhang, Y., & Yang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.129 · Cited by 66
Yue, W., Li, Y., Ou, D., & Yang, Q. (2019) · IUBMB Life · doi:10.1002/iub.2046 · Cited by 61
Zhang, X., Lu, J., Zhang, Q., Luo, Q., & Liu, B. (2021) · Biological Research · doi:10.1186/s40659-021-00335-5 · Cited by 60
Wei, Q., Tu, Y., Zuo, L., Jia, Z., Chang, Z., Zou, Y., & Qiu, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117142 · Cited by 59
Zhang, B., Hao, Z., Zhou, W., Zhang, S., Sun, M., Li, H., Hou, N., Jing, C., & Zhao, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.1959493 · Cited by 56
Xu, L., Wang, S., Li, B., Sun, A., Zou, Y., & Ge, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12463 · Cited by 55
Self-citationYan, F., Li, H.-M., Li, S., He, S.-H., Dai, W.-P., Li, Y., Wang, T., Shi, M., Yuan, H., Xu, Z., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.08.016 · Cited by 47
Shi, G., Liu, D., Zhou, B., Liu, Y., Hao, B., Yu, S., Wu, L., Wang, M., Song, Z., Wu, C., et al. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000775 · Cited by 46
Zeng, J., Tao, J., Xi, L., Zuo, W., & Liu, L.-S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4886 · Cited by 44
Zhang, J.-J., Liu, W.-Q., Peng, J.-J., Ma, Q., Peng, J., & Luo, X. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.009 · Cited by 43
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H2S System
Peng, J., Tang, Z., Ren, Z., He, B., Zeng, Y., Liu, L.-S., Wang, Z., Wei, D., Zheng, X., & Jiang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00486 · Cited by 38
Chen, J., Tao, J., Zhang, X., Xia, L., Zeng, J., Hai, Z., Wei, D., Lv, Y.-C., Li, G., & Wang, Z. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5151 · Cited by 38
Fujimura, N., Jitsuiki, D., Maruhashi, T., Mikami, S., Iwamoto, Y., Kajikawa, M., Chayama, K., Kihara, Y., Noma, K., Goto, C., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237263 · Cited by 35
Harnessing polyphenol power by targeting eNOS for vascular diseases
Das, M., Devi, K. P., Belwal, T., Devkota, H. P., Tewari, D., Sahebnasagh, A., Nabavi, S. F., Kashani, H. R. K., Rasekhian, M., Xu, S., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1971153 · Cited by 35
Self-citationHu, Y., Xu, R., He, Y., Zhao, Z., Mao, X., Lin, L., & Hu, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11147 · Cited by 34
Khaidakov, M., Mitra, S., Wang, X., Ding, Z., Bora, N. S., Lyzogubov, V. V., Romeo, F., Schichman, S. A., & Mehta, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047421 · Cited by 32
Hua, Z., Ma, K., Liu, S., Yue, Y., Cao, H., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117334 · Cited by 31
Regulatory Non-coding RNAs in Atherosclerosis
Schober, A., Maleki, S. S., & Nazari-Jahantigh, M. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_423 · Cited by 31
Sharif, S. B., Hashemzadeh, S., Ardehaie, R. M., Eftekharsadat, A., Ghojazadeh, M., Mehrtash, A., Estiar, M. A., Teimoori‐Toolabi, L., & Sakhinia, E. (2016) · Oncology Letters · doi:10.3892/ol.2016.5327 · Cited by 30
Wu, C., Zhou, Z., Wang, B., Ke, Z., Ge, Z., & Zhang, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27469 · Cited by 30
Shi, Y., Lüscher, T. F., & Camici, G. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107787 · Cited by 29
Endothelial long non-coding RNAs regulated by oxidized LDL
Singh, K. K., Matkar, P. N., Pan, Y., Quan, A., Gupta, V., Teoh, H., Al-Omran, M. A., & Verma, S. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2984-2 · Cited by 27
Miao, J., Wang, B., Shao, R., & Wang, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4873 · Cited by 27
Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2
Li, W., Wang, C., Zhang, D., Zeng, K., Xiao, S., Chen, F., & Luo, J. (2021) · Aging · doi:10.18632/aging.202973 · Cited by 27
Qin, X., & Guo, J. (2020) · Medical Science Monitor · doi:10.12659/msm.921877 · Cited by 22
Zeng, J., Tao, J., Xia, L., Zeng, Z., Chen, J., Wang, Z., Meng, J., & Liu, L.-S. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0279 · Cited by 22
Chen, D., Wang, K., Zheng, Y., Wang, G., & Jiang, M. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000974 · Cited by 22
Wu, H., Liu, T., & Hong, H. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03793-9 · Cited by 21
LncRNA MIAT Mediates ox-LDL-Induced Endothelial Cell Injury Via miR-206/RAB22A Axis
Gao, Y., Yue, J., & Huang, Z. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.02.029 · Cited by 20
Li, S., Huang, T., Qin, L., & Yin, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.650374 · Cited by 20
NLRP3 activation in endothelia promotes development of diabetes-associated atherosclerosis
Huang, D., Gao, W. Q., Zhong, X., & Ge, J. (2020) · Aging · doi:10.18632/aging.103666 · Cited by 19
Self-citationGPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
Liu, R., Cheng, F., Zeng, K., Li, W., & Lan, J. (2020) · ACS Omega · doi:10.1021/acsomega.0c03581 · Cited by 19
Wang, X., Li, X., Wu, Y., & Song, Y. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00496-9 · Cited by 18
The effect of myeloperoxidase-oxidized LDL on THP-1 macrophage polarization and repolarization
Bazzi, S. I., Frangie, C., Azar, E., & Daher, J. (2022) · Innate Immunity · doi:10.1177/17534259221090679 · Cited by 18
Su, Q., Dong, X., Tang, C., Wei, X., Hao, Y., & Wu, J. (2021) · Open Medicine · doi:10.1515/med-2021-0209 · Cited by 16
Ning, D.-S., Ma, J., Peng, Y.-M., Li, Y., Chen, Y.-T., Li, S., Liu, Z., Li, Y., Zhang, Y., Jian, Y., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.019 · Cited by 16
Cited by
Endothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis
Młynarska, E., Bojdo, K., Frankenstein, H., Krawiranda, K., Kustosik, N., Lisińska, W., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010096 · Cited by 87
Saeedi Saravi, S. S., Pugin, B., Constancias, F., Shabanian, K., Spalinger, M., Thomas, A., Le Gludic, S., Shabanian, T., Karsai, G., Colucci, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00864-8 · Cited by 68
Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons
Li, H., Shan, W., Zhao, X., & Sun, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051965 · Cited by 32
Metadata
- Authors
- Jiang, H., Zhou, Y., Nabavi, S. M., Sahebkar, A., Little, P. J., Xu, S., Weng, J., & Ge, J.
- Venue
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2022-06-01
- Volume
- 9
- Pages
- 925923-925923
- ISSN
- 2297-055X (ISSN-L)
- OpenAlex
- W4281869757
- Cited by
- 323
- References
- 71
- FWCI
- 16.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.